| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/11/2001 | WO2001001974A2 Naaladase inhibitors in anxiety and memory disorders |
| 01/11/2001 | WO2001001973A2 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 01/11/2001 | WO2001001972A2 SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |
| 01/11/2001 | WO2001001970A2 New uses potassium channel openers, such as the treatment of epilepsy |
| 01/11/2001 | WO2001001963A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001962A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001958A1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
| 01/11/2001 | WO2001001956A2 Solid preparations containing paroxetine |
| 01/11/2001 | WO2001001939A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000066108A3 Anticonvulsant derivatives useful in treating cocaine dependency |
| 01/11/2001 | WO2000062801A3 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/11/2001 | WO2000062800A3 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | WO2000061189A3 Water-soluble compositions of bioactive lipophilic compounds |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | WO2000057851A3 High potency dihydroergotamine compositions |
| 01/11/2001 | WO2000053738A3 Methods and compositions for regulating memory consolidation |
| 01/11/2001 | WO2000053596A3 Imidazole compounds as histamine h3 ligands |
| 01/11/2001 | WO2000053217A3 Prevention of fetal alcohol syndrome and neuronal cell death with adnf polypeptides |
| 01/11/2001 | WO2000051546A3 Bupropion metabolites and methods of their synthesis and use |
| 01/11/2001 | WO2000029551B1 Cells, culture methods, and their use in autologous transplantation therapy |
| 01/11/2001 | DE19932315A1 Benzoylpyridazine Benzoylpyridazine |
| 01/11/2001 | DE19932314A1 Benzofuranderivate Benzofuran derivatives |
| 01/11/2001 | CA2643231A1 Norepinephrine reuptake inhibitors and methods of using the same |
| 01/11/2001 | CA2527931A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/11/2001 | CA2380875A1 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | CA2380866A1 Selective npy (y5) antagonists |
| 01/11/2001 | CA2378467A1 Pharmaceutical compositions and methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2377931A1 Novel mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | CA2377382A1 Prevention and treatment of amyloid-associated disorders |
| 01/11/2001 | CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | CA2376495A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | CA2374931A1 Solid preparations containing paroxetine |
| 01/11/2001 | CA2373953A1 A synergistic combination: gabapentin and pregabalin |
| 01/11/2001 | CA2373883A1 Method of reducing neuronal injury or apoptosis |
| 01/11/2001 | CA2373877A1 Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone |
| 01/11/2001 | CA2372742A1 Double transgenic animals as models for neurodegenerative disease |
| 01/11/2001 | CA2341984A1 Complexes of paroxetine, with cyclodextrines or cyclodextrin derivatives |
| 01/10/2001 | EP1067386A2 Inhibition of tau-tau-association |
| 01/10/2001 | EP1067136A1 New peptide derivatives |
| 01/10/2001 | EP1066835A1 Composition containing the pepino extracts for lowering the concentration of alcohol in the blood and method for producing the same |
| 01/10/2001 | EP1066830A2 Uses and compositions for treating primary and secondary tumors of the central nervous system (cns) |
| 01/10/2001 | EP1066829A1 Stable microemulsions for administration of fatty acids, and use thereof |
| 01/10/2001 | EP1066824A2 Stimulative agent and stimulative perfume composition |
| 01/10/2001 | EP1066377A1 Methods for prevention and treatment of cancer |
| 01/10/2001 | EP1066297A1 Phosphinic acid derivatives |
| 01/10/2001 | EP1066288A2 Novel compounds |
| 01/10/2001 | EP1066287A1 Azatricyclic compounds |
| 01/10/2001 | EP1066286A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 01/10/2001 | EP1066285A1 Antagonists of gonadotropin releasing hormone |
| 01/10/2001 | EP1066283A2 Substituted indolealkanoic acids |
| 01/10/2001 | EP1066273A1 Metalloproteinase inhibitors |
| 01/10/2001 | EP1066245A1 Novel local anesthetic compounds and uses |
| 01/10/2001 | EP1066042A2 Steroidal saponins for treating alzheimer's disease |
| 01/10/2001 | EP1066039A1 Substituted quinazolines and analogs and the use thereof |
| 01/10/2001 | EP1066038A2 Use of cabergoline in the treatment of restless legs syndrome |
| 01/10/2001 | EP1066036A1 Agents with serotonin-related activity for the treatment for sleep apnea |
| 01/10/2001 | EP1066033A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 01/10/2001 | EP1066027A1 Pharmaceutical composition of topiramate |
| 01/10/2001 | EP1065931A1 Compositions containing a combination of a creatine compound and a second agent |
| 01/10/2001 | EP0796103B1 Use of incense in the treatment of alzheimer's disease |
| 01/10/2001 | CN1279682A bicyclic kinase inhibitors |
| 01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 01/10/2001 | CN1279676A Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride |
| 01/10/2001 | CN1279674A 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analoguse), their preparation and their use in the treatment of neurological disorders |
| 01/10/2001 | CN1279673A ((Cyclo) alkyl substituted-.gamma.-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 01/10/2001 | CN1279670A Substituted oximes as neurokinin antagonists |
| 01/10/2001 | CN1279669A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 01/10/2001 | CN1279667A 4(3)-substituted-4(3)-aminonethyl-(thioxo)pyran(thiapyran)or-piperidine derivatives(=gabapendin analogues), their preparation and their use in treatment of neurological disorders |
| 01/10/2001 | CN1279666A NPY antagonists |
| 01/10/2001 | CN1279614A Antistress agents and functional foods |
| 01/10/2001 | CN1279611A Mechod for treating postmenopausal women using ultra-low-doses of estrogen |
| 01/10/2001 | CN1279609A Combination of selective 5-HT antagonist and selective h5-HT antagonist or partial agonist |
| 01/10/2001 | CN1279608A Formulations comprising dissolved paroxetine |
| 01/10/2001 | CN1279606A Use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 01/10/2001 | CN1279604A Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration. |
| 01/10/2001 | CN1279582A Serotonin containing formulation or oral administration and method of use |
| 01/10/2001 | CN1279104A Medical wine for treating ischias |
| 01/10/2001 | CN1279082A Drup-dropping medicine and preparing thereof |
| 01/10/2001 | CN1279081A Drug-dropping medicine and preparing process thereof |
| 01/10/2001 | CN1279071A Chinese medicine for dropping drug |
| 01/10/2001 | CN1060479C Preparation method for inidazole derivatives |
| 01/10/2001 | CN1060364C Anti-neurosism preparation and its preparing technology |
| 01/10/2001 | CN1060342C Use of balloonfish liver oil in treatment of drug dependence |
| 01/09/2001 | US6172250 Hydrolysis of an organosilicon compounds |
| 01/09/2001 | US6172239 Psychological, nervous system disorders |
| 01/09/2001 | US6172229 1-phenyl-4-benzylpiperazines; dopamine receptor subtype specific ligands |
| 01/09/2001 | US6172105 3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5 -carboxamide hydrogen tartrate synergistic mixture; anxiolytic agents, antidepressents; obsessive compulsive and psychological disorders |
| 01/09/2001 | US6172097 Treating psychological, eating, sexual, and nervous system disorders; anxiolytic, adrenergic blocking, and antidepressant agents; serotonin reuptake inhibitors |
| 01/09/2001 | US6172088 Administering gonadotropin releasing hormone inhibitor |
| 01/09/2001 | US6172086 Methods and compositions for stimulating neurite growth |
| 01/09/2001 | US6172080 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/09/2001 | US6172077 Tachykinin inhibitors; analgesics, antiinflammatory agents, antiemetics; neuralgia, headaches |
| 01/09/2001 | US6172072 Heterocyclically substituted benzamides and their use in fighting diseases |
| 01/09/2001 | US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 01/09/2001 | US6172067 Analgesics, antiinflammatory agents |
| 01/09/2001 | US6172060 Therapy for sexual disorders |